MDLinx Conference Coverage – July 2016

The MDLinx editors covered 4 interesting medical conferences during the month of July with a focus on dermatology, AIDS, ENT, cancer, and gastrointestinal cancer. Some of the highlights follow. As reported at the ESMO 18th World Congress on Gastrointestinal Cancer held in Barcelona, Spain, June 29–July 2 July, anti-IL-1α antibody is effective in patients with metastatic colorectal cancer who have failed standard therapy (oxaliplatin and irinotecan). Patients treated with anti-IL-1α monoclonal antibody (n=207) had a 33% treatment responsecompared with 19% in patients treated with placebo. There was also a 26% relative risk reduction in adverse events. Use of a free […]